Annelie Blumrich
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Converting PROMIS®-29 v2.0 profile data to SF-36 physical and mental component summary scores in patients with cardiovascular disorders.
Journal: Health and quality of life outcomes
Published: January 19, 2024
Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol-Induced Cardiac Damage.
Journal: Journal of the American Heart Association
Published: July 06, 2021
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function.
Journal: iScience
Published: April 14, 2021
Evaluation of a commercial multi-dimensional echocardiography technique for ventricular volumetry in small animals.
Journal: Cardiovascular ultrasound
Published: January 22, 2018
Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: September 21, 2017
Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy.
Journal: Journal of cardiovascular pharmacology
Published: February 10, 2016
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
Journal: Journal of cancer research and clinical oncology
Published: May 29, 2015
Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate.
Journal: The Journal of biological chemistry
Published: February 13, 2015
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 30, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026